Antibiotics
More action needed on antibiotic resistance
July 25, 2014Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
Cameron’s antibiotics plan not enough
July 8, 2014Research and Development, Sales and Marketing Antibiotics, BBC, NHS, UK, david cameron, governement
UK prime minister David Cameron’s reaction to antibiotic resistance is not urgent enough and doctors are continuing to prescribe antibiotics …
World facing medical ‘dark ages’ over antibiotic resistance
July 2, 2014Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance
The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …
Sanofi to research new types of antibiotics
July 6, 2011Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news
Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …
GSK sells antibiotics assets to Dr Reddy’s
November 24, 2010Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK
Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
AZ signs antibiotic deal with Forest Laboratories
August 13, 2009Research and Development, Sales and Marketing Antibiotics, Forest
AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
